WellNow Clinical Research Chronic Migraine Medication Investigation


This study seeks participants to help us evaluate the effectiveness of promising new medication focused on preventing migraines. Because this medication focuses on reducing the number of migraines per month, participants must have had at least 8 migraines each month, with at least 1 headache-free day. This study will last at least 30 weeks and consist of 9 study appointments during that time. 

Qualified Participants are: 

  • Experiencing chronic migraines (at least 8 a month) 


10575 Springfield Ave, Suite A

Cincinnati, Ohio 45215

(513) 978-5070

Chronic Migraine Medication Investigation - Cincinnati

WellNow Urgent Care & Research partners with multinational pharmaceuticals, biotechnology companies, medical device manufacturers & CROs to help drive improvements to health and well-being. In our 15 years of research, WellNow has had over 17,000 visits to our network of clinical research sites.
Facebook for wellnow research
Youtube for WN research
Twitter for WN Research